Strata Skin Sciences – Consensus Indicates Potential 166.7% Upside

Broker Ratings

Strata Skin Sciences found using ticker (SSKN) have now 3 analysts covering the stock with the consensus suggesting a rating of ‘Strong_Buy’. The range between the high target price and low target price is between 5 and 3 with the average target price sitting at 3.92. Now with the previous closing price of 1.47 this would indicate that there is a potential upside of 166.7%. The 50 day MA is 1.51 and the 200 day moving average is 1.39. The market cap for the company is $47m. You can visit the company’s website by visiting: http://www.strataskinsciences.com

STRATA Skin Sciences, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States and Asia. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC excimer laser and VTRAC lamp systems that are used for the treatment of skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. The company distributes its products internationally through distributors, and domestically directly to physicians. STRATA Skin Sciences was founded in 1989 and is based in Horsham, Pennsylvania.

You can now share this on Stocktwits, just click the logo below and add the ticker in the text to be seen.

Share on Stocktwits

Good news travels fast (but only if you make that happen):

Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on facebook
Facebook
Share on email
Email
Share on reddit
Reddit

AIM All Share Index